Irbesartan Evolugen

Irbesartan, the active ingredient in Irbesartan Evolugen, is an Angiotensin II receptor blocker (ARB) presented as an oral tablet for oral use. It is employed to lower high blood pressure and to protect kidney function in patients with diabetic kidney disease. GNH USA supplies Irbesartan Evolugen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irbesartan acts on the renin‑angiotensin‑aldosterone system to control blood pressure and renal disease progression. Hypertension: reduces systolic and diastolic blood pressure in adults. Diabetic nephropathy: slows the decline of renal function in type 2 diabetes. Proteinuric kidney disease: decreases urinary protein excretion and supports renal preservation.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue - Nausea Serious or Rare Side Effects: - Angioedema (swelling of face, lips, tongue) - Severe hyperkalemia (high blood potassium) - Acute renal impairment or failure

Before starting Irbesartan, consider the following precautions: - Monitor blood pressure regularly: ensure therapeutic response and avoid hypotension. - Assess renal function: check serum creatinine and eGFR at baseline and periodically. - Check serum potassium: avoid hyperkalemia, especially when combined with potassium‑sparing agents. - Avoid use in pregnancy: drug is classified as Category D and may cause fetal harm. - Use caution in hepatic impairment: dose adjustments may be required. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Irbesartan may interact with several medicines that affect potassium balance or renal function. Major Interactions (Avoid): - Aliskiren (in patients with diabetes): increased risk of renal dysfunction. - Potassium‑sparing diuretics (e.g., spironolactone): risk of severe hyperkalemia. - ACE inhibitors (e.g., enalapril): combined use can cause excessive potassium rise and renal impairment. - NSAIDs (e.g., ibuprofen): may diminish antihypertensive effect and impair kidney function. Moderate Interactions (Monitor Closely): - Thiazide diuretics: may enhance antihypertensive effect, requiring dose adjustment. - Lithium: increased lithium levels, monitor for toxicity. - Cyclosporine: may increase serum creatinine, monitor renal function.